《乳腺癌（英文版）》内容包括乳腺癌的流行病学；乳腺癌基础研究进展；乳腺癌影像学检查；乳腺癌的内科**；乳腺癌的手术**；乳腺癌的激素**；乳腺癌的放化疗；靶向****；纳米**和预后及转归等方面内容。

Epidemiology of Breast Cancer
Epidemiology and prognosis of breast cancer in young women
Lack of patient-reported outcomes assessment in phase III breast cancer studies： a missed opportunity for informed decision making
Advances in Basic Research of Breast Cancer
Breast cancer in the young： role of the geneticist
An update on the genomic landscape of breast cancer： new opportunity for personalized therapy?
Towards the elucidation of the mechanisms underlying breast cancer mutations
Members of the BRCA1 complexes as new susceptibility genes for breast cancer
APOBEC3B spreads somatic mutations in breast cancer genome
From genomic data analysis to drug development： a new generation of trials using molecular marker assessment in breast cancer
MET deregulation in breast cancer
Circulating free DNA in the management of breast cancer
Imaging Examination of Breast Cancer
Breast imaging in the young： the role of magnetic resonance imaging in breast cancer screening，diagnosis and follow-up
Treatment of Breast Cancer
Challenges in managing breast cancer during pregnancy
Premature menopause in young breast cancer： effects on quality of life and treatment interventions
Surgical Treatment
Conservative mastectomies for breast cancer and risk-reducing surgery： the Memorial Sloan Kettering Cancer Center experience
Oncoplastic techniques in breast surgery for special therapeutic problems
Oncological safety of prophylactic breast surgery： skin-sparing and nipple-sparing versus total mastectomy
Anatomy relevant to conservative mastectomy
Breast reconstruction following conservative mastectomies： predictors of complications and outcomes
Surgical management of breast cancer in China： the Fudan University Shanghai Cancer Center experience
Endocrine Therapy
Paradigm of polyendocrine therapy in endocrine responsive breast cancer： the role of fulvestrant
Bisphosphonates in the adjuvant treatment of young women with breast cancer： the estrogen rich is a poor candidate！
Hormonal therapies in young breast cancer patients： when， what and for how long?
A balancing act for breast cancer? Everolimus for hormone receptor positive patients
Chemotherapy
Treatment of breast cancer in young women： do we need more aggressive therapies?
Neoadjuvant bevacizumab and chemotherapy in breast cancer
Radiotherapy
Impact of preoperative magnetic resonance imaging in breast cancer patients candidates for an intraoperative partial breast irradiation
First year experience with IORT for breast cancer at the Geneva University Hospitals
CyberKnife stereotaetie body radiotherapy and CyberKnife aeeelerated partial breast irradiation for the treatment of early breast cancer
Brest experience in intraoperative radiotherapy for breast cancer
Intraoperative radiotherapy with electrons （ELIOT） for early breast cancer： the European Institute of Oneology experience
Comparison of the proliferative and elonogenie growth capacity of wound fluid from breast cancer patients treated with and without intraoperative radiotherapy
The use of postoperative radiation after nipple sparing mastectomy
Optimal management of sentinel lymph node positive biopsy patients in early breast cancer
Targeted Therapy
Should trastuzumab be administered concomitantly with anthracycline in women with early， HER2-positive breast cancer?
Pertuzumab in metastatic breast cancer： unanswered questions
Pertuzumab： a step forward in treating HER2-positive breast cancer
Bevacizumab： Where do we go from here in breast cancer?
Lapatinib as a therapeutic option in brain metastases from HER2+ breast cancer
The ALTERNATE trial： assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2- invasive breast cancer
Nanoparticle Therapy
Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer
Prognosis of Breast Cancer
Fertility counseling of young breast cancer patients
Sexuality and breast cancer： prime time for young patients
Breast cancer and sleep disturbance： more than simply a quality of life concern
Brain metastases in HER2 positive breast cancer： the next hurdle
Brain metastases in HER2-positive breast cancer： challenges and opportunities